Verve Therapeutics, Inc. Intellectual Property Contracts & Agreements
3 Contracts & Agreements
- License Agreements (3 contracts)
- License Agreement, dated October 4, 2021, by and between the Registrant and Novartis Pharma AG, as amended (Filed With SEC on February 27, 2024)
- Cas9 License Agreement, dated as of March 15, 2019, by and among the Registrant, The President and Fellows of Harvard College and The Broad Institute, Inc., as amended (Filed With SEC on May 28, 2021)
- Non-Exclusive License Agreement, dated as of October 14, 2020, by and between the Registrant and Acuitas Therapeutics, Inc (Filed With SEC on May 28, 2021)
